findmyKOL
Clinical trialNCT05188729CompletedPhase 2Interventional

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

SponsorVerrica Pharmaceuticals Inc.Enrollment92Basal Cell CarcinomaCancer of the SkinCancer of the Skin, Basal CellCarcinomaSkin Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Therapeutics Clinical Research

    San Diego, California, United States

  • Clearlyderm

    Boca Raton, Florida, United States

  • Life Clinical Trials

    Coral Springs, Florida, United States

  • Florida Center for Dermatology

    Saint Augustine, Florida, United States

  • Gwinnett Dermatology

    Snellville, Georgia, United States

  • Affinity Health

    Oakbrook Terrace, Illinois, United States

  • Dermassociates

    Rockville, Maryland, United States

  • Lawrence J Green, Md Llc

    Rockville, Maryland, United States

  • Activmed Research - Borthwick

    Portsmouth, New Hampshire, United States

  • Upmc St. Margaret

    Pittsburgh, Pennsylvania, United States

  • Austin Institute of Clinical Research - Dripping Springs

    Dripping Springs, Texas, United States

  • Austin Institute of Clinical Research - Houston

    Houston, Texas, United States

  • Austin Institute of Clinical Research - Pflugerville

    Pflugerville, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Feb 2022
Primary completion
15 Apr 2024
Completion
15 Apr 2024
Last update posted
18 Jun 2025
Registered enrollment
92
Registry id
NCT05188729

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.